BIRC5 and gastric cancer: In addition, the upregulation of Survivin by HIF-1α and PTEN contributed to cisplatin (CDDP) resistance, indicating that inhibition of these pathways may be a potential strategy for overcoming CDDP resistance in the treatment of gastric cancer [29].